Pertussis: Vaccine Failure, Not Failure to Vaccinate

Print

By the Children’s Heath Defense Team

This is the latest peer reviewed science-not “vaccine misinformation.” These studies show that the Pertussis (whooping cough) vaccine has now failed. Studies show that by five years after completion of the DTaP series, children were up to 15 times more likely to acquire pertussis compared to the first year after the series. California schools are now suffering a Pertussis outbreak (3,455 cases in 2018 compared to 14 Measles cases) affecting primarily vaccinated children.

With mandates legislation sweeping across the nation, the stakes are too high for citizens to tolerate laziness, scientific illiteracy and a default to collegiality in our elected leaders. It’s time for lawmakers to fact-check their sources.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530967/

“More recent studies show that by 5 years after completion of a DTaP series, children were up to 15 times more likely to acquire pertussis compared to the first year after the series. Studies have also documented rapid decline in pertussis antibodies within as few as 2–3 years of the most recent aP vaccination, often to pre-vaccination levels and although antibody levels alone are not necessarily indicative of waning immunity, in this case given the higher risk of infection after aP vaccine with time, it is strongly suggestive of it.”

https://childrenshealthdefense.org/…/the-112-year-odyssey-…/

“In the last 13 years, major pertussis epidemics have occurred in the United States, and numerous studies have shown the deficiencies of DTaP vaccines, including the small number of antigens that the vaccines contain and the type of cellular immune response that they elicit. Because of linked-epitope suppression, all children who were primed by DTaP vaccines will be more susceptible to pertussis throughout their lifetimes, and there is no easy way to decrease this increased lifetime susceptibility.”

https://bmcmedicine.biomedcentral.com/…/1…/s12916-015-0382-8

“In this paper, we have presented empirical evidence — from both case and genomic data — for asymptomatic B. pertussis transmission following the switch from the wP to the aP vaccine in the US and UK. Then, using mathematical and computational transmission models, we have demonstrated that an aP vaccine which blocks symptomatic disease but not asymptomatic transmission is able to account for the observed increase in B. pertussis incidence…public health authorities may be facing a situation similar to that of polio, where vaccinated individuals can still transmit infection.”

The Research (Click on each image to see each full study or download the slides as a PowerPoint presentation):



